Top Key Companies for Stress Urinary Incontinence Device Market: Coloplast A/S, Contura Ltd, Laborie Inc (Cogentix Medical), Atlantic Therapeutics, Boston Scientific Corporation, Johnson & Johnson Services Inc, Coopersurgical Inc, Megyn Products Inc, Cousin Biotech, Caldera Medical, Betatech Medical, Feg Textiltechnik Mbh, Affluent Medical, Pfm Medical Ag, Caldera Medical Inc, Neomedic International, Euromed, Zephyr Surgical Implants.
Global Stress Urinary Incontinence Device Market Size was estimated at USD 278.2 million in 2022 and is projected to reach USD 544.72 million by 2028, exhibiting a CAGR of 11.85% during the forecast period.
Global Stress Urinary Incontinence Device Market Overview And Scope:
The Global Stress Urinary Incontinence Device Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Stress Urinary Incontinence Device utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Stress Urinary Incontinence Device Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Stress Urinary Incontinence Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Stress Urinary Incontinence Device market.
Global Stress Urinary Incontinence Device Market Segmentation
By Type, Stress Urinary Incontinence Device market has been segmented into:
Sling Systems
Vaginal Pessary Devices
Artificial Urinary Sphincter (AUS)
Pelvic Floor Muscle Stimulator
By Application, Stress Urinary Incontinence Device market has been segmented into:
Hospitals
Gynecological Clinics
Homecare Settings
Regional Analysis of Stress Urinary Incontinence Device Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Stress Urinary Incontinence Device Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Stress Urinary Incontinence Device market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Stress Urinary Incontinence Device market.
Top Key Companies Covered in Stress Urinary Incontinence Device market are:
Coloplast A/S
Contura Ltd
Laborie Inc (Cogentix Medical)
Atlantic Therapeutics
Boston Scientific Corporation
Johnson & Johnson Services Inc
Coopersurgical Inc
Megyn Products Inc
Cousin Biotech
Caldera Medical
Betatech Medical
Feg Textiltechnik Mbh
Affluent Medical
Pfm Medical Ag
Caldera Medical Inc
Neomedic International
Euromed
Zephyr Surgical Implants
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Stress Urinary Incontinence Device Market by Type
5.1 Stress Urinary Incontinence Device Market Overview Snapshot and Growth Engine
5.2 Stress Urinary Incontinence Device Market Overview
5.3 Sling Systems
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Sling Systems: Geographic Segmentation
5.4 Vaginal Pessary Devices
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Vaginal Pessary Devices: Geographic Segmentation
5.5 Artificial Urinary Sphincter (AUS)
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Artificial Urinary Sphincter (AUS): Geographic Segmentation
5.6 Pelvic Floor Muscle Stimulator
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Pelvic Floor Muscle Stimulator: Geographic Segmentation
Chapter 6: Stress Urinary Incontinence Device Market by Application
6.1 Stress Urinary Incontinence Device Market Overview Snapshot and Growth Engine
6.2 Stress Urinary Incontinence Device Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Gynecological Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Gynecological Clinics: Geographic Segmentation
6.5 Homecare Settings
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Homecare Settings: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Stress Urinary Incontinence Device Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Stress Urinary Incontinence Device Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Stress Urinary Incontinence Device Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 COLOPLAST A/S
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CONTURA LTD
7.4 LABORIE INC (COGENTIX MEDICAL)
7.5 ATLANTIC THERAPEUTICS
7.6 BOSTON SCIENTIFIC CORPORATION
7.7 JOHNSON & JOHNSON SERVICES INC
7.8 COOPERSURGICAL INC
7.9 MEGYN PRODUCTS INC
7.10 COUSIN BIOTECH
7.11 CALDERA MEDICAL
7.12 BETATECH MEDICAL
7.13 FEG TEXTILTECHNIK MBH
7.14 AFFLUENT MEDICAL
7.15 PFM MEDICAL AG
7.16 CALDERA MEDICAL INC
7.17 NEOMEDIC INTERNATIONAL
7.18 EUROMED
7.19 ZEPHYR SURGICAL IMPLANTS
Chapter 8: Global Stress Urinary Incontinence Device Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Sling Systems
8.2.2 Vaginal Pessary Devices
8.2.3 Artificial Urinary Sphincter (AUS)
8.2.4 Pelvic Floor Muscle Stimulator
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Gynecological Clinics
8.3.3 Homecare Settings
Chapter 9: North America Stress Urinary Incontinence Device Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Sling Systems
9.4.2 Vaginal Pessary Devices
9.4.3 Artificial Urinary Sphincter (AUS)
9.4.4 Pelvic Floor Muscle Stimulator
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Gynecological Clinics
9.5.3 Homecare Settings
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Stress Urinary Incontinence Device Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Sling Systems
10.4.2 Vaginal Pessary Devices
10.4.3 Artificial Urinary Sphincter (AUS)
10.4.4 Pelvic Floor Muscle Stimulator
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Gynecological Clinics
10.5.3 Homecare Settings
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Stress Urinary Incontinence Device Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Sling Systems
11.4.2 Vaginal Pessary Devices
11.4.3 Artificial Urinary Sphincter (AUS)
11.4.4 Pelvic Floor Muscle Stimulator
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Gynecological Clinics
11.5.3 Homecare Settings
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Stress Urinary Incontinence Device Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Sling Systems
12.4.2 Vaginal Pessary Devices
12.4.3 Artificial Urinary Sphincter (AUS)
12.4.4 Pelvic Floor Muscle Stimulator
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Gynecological Clinics
12.5.3 Homecare Settings
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Stress Urinary Incontinence Device Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Sling Systems
13.4.2 Vaginal Pessary Devices
13.4.3 Artificial Urinary Sphincter (AUS)
13.4.4 Pelvic Floor Muscle Stimulator
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Gynecological Clinics
13.5.3 Homecare Settings
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Stress Urinary Incontinence Device Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Sling Systems
14.4.2 Vaginal Pessary Devices
14.4.3 Artificial Urinary Sphincter (AUS)
14.4.4 Pelvic Floor Muscle Stimulator
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Gynecological Clinics
14.5.3 Homecare Settings
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Stress Urinary Incontinence Device Scope:
|
Report Data
|
Stress Urinary Incontinence Device Market
|
|
Stress Urinary Incontinence Device Market Size in 2022
|
USD 278.20 million
|
|
Stress Urinary Incontinence Device CAGR 2023 - 2030
|
11.85%
|
|
Stress Urinary Incontinence Device Base Year
|
2022
|
|
Stress Urinary Incontinence Device Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Coloplast A/S, Contura Ltd, Laborie Inc (Cogentix Medical), Atlantic Therapeutics, Boston Scientific Corporation, Johnson & Johnson Services Inc, Coopersurgical Inc, Megyn Products Inc, Cousin Biotech, Caldera Medical, Betatech Medical, Feg Textiltechnik Mbh, Affluent Medical, Pfm Medical Ag, Caldera Medical Inc, Neomedic International, Euromed, Zephyr Surgical Implants.
|
|
Key Segments
|
By Type
Sling Systems
Vaginal Pessary Devices
Artificial Urinary Sphincter (AUS)
Pelvic Floor Muscle Stimulator
By Applications
Hospitals
Gynecological Clinics
Homecare Settings
|
Research Methodology
